r-HuEPO

r-HuEPO

epoetin (recombinant human erythropoietin).

r-HuEPO

abbreviation for recombinant human erythropoietin.
Mentioned in ?
References in periodicals archive ?
The investigators evaluated the impact of r-HuEPO therapy on HRQL in predialysis chronic renal disease patients with anemia.
Management of iron substitution during r-HuEPO therapy in chronic renal failure patients.
What is the optimum frequency of administration of r-HuEPO for correcting anemia in hemodialysis patients?
Novel erythropoiesis stimulating protein (NESP) safely maintains hemoglobin concentrations in hemodialysis patients as effectively as r-HuEPO when administered once weekly (Abstract).
In addition, treatment with r-HuEPO prior to initiation of dialysis has been associated with improved mortality after initiation of renal replacement therapy (Fink, Blahut, Reddy, & Light, 2003).
Organized algorithmically, the clinic was designed to efficiently monitor and treat a greater number of patients with r-HuEPO and intravenous iron.
The use of r-HuEPO is expanding rapidly, and new preparations with greater potency and longer half-lives are now on the market (8).
Therefore, targeting the Hgb value above the current recommendation with r-HuEPO is not warranted until further evidence supports its safety and efficacy.
He has shown the clinical value of reticulocyte parameters in the setting of r-HuEPO use and in the diagnosis of iron deficiency in children.
Novel erythropoiesis stimulating protein (NESP) safely maintains hemoglobin concentration levels in hemodialysis patients as effectively as r-HuEPO when administered once weekly.
La r-HuEPO est une version recombinante ou de synthese (reproduite par genie genetique) de l'EPO.
The use of r-HuEPO has quickly led to the understanding that an adequate iron supply is critical to obtaining a therapeutic response (4).